Michael Wulfsohn
Overview
Explore the profile of Michael Wulfsohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Markowitz M, Zolopa A, Squires K, Ruane P, Coakley D, Kearney B, et al.
J Antimicrob Chemother
. 2014 Feb;
69(5):1362-9.
PMID: 24508897
Background: Tenofovir alafenamide (formerly GS-7340) is a new oral prodrug of tenofovir, a nucleotide analogue that inhibits HIV-1 reverse transcription. Unlike the currently marketed tenofovir prodrug, tenofovir disoproxil fumarate, tenofovir...
2.
McColl D, Margot N, Wulfsohn M, Coakley D, Cheng A, Miller M
J Acquir Immune Defic Syndr
. 2004 Oct;
37(3):1340-50.
PMID: 15483463
Study GS-99-907 was a 48-week, phase 3, double-blind, placebo-controlled intensification trial of tenofovir disoproxil fumarate (tenofovir DF). Antiretroviral-experienced patients added tenofovir DF 300 mg once daily to their existing regimen....
3.
Miller M, Margot N, Lu B, Zhong L, Chen S, Cheng A, et al.
J Infect Dis
. 2004 Feb;
189(5):837-46.
PMID: 14976601
Results from 2 placebo-controlled intensification trials of tenofovir disoproxil fumarate (DF) in treatment-experienced human immunodeficiency type 1 (HIV-1)-infected patients (n=332) were integrated to determine the effects of resistance at baseline...
4.
Squires K, Pozniak A, Pierone Jr G, Steinhart C, Berger D, Bellos N, et al.
Ann Intern Med
. 2003 Sep;
139(5 Pt 1):313-20.
PMID: 12965939
Background: Resistance to antiretroviral agents remains a leading cause of treatment failure for patients infected with HIV-1. Objective: To describe the efficacy and safety of tenofovir disoproxil fumarate (tenofovir DF)...
5.
Westland C, Yang H, Delaney 4th W, Gibbs C, Miller M, Wulfsohn M, et al.
Hepatology
. 2003 Jun;
38(1):96-103.
PMID: 12829991
Seven hundred nucleoside treatment-naive patients were enrolled in two phase 3 trials of adefovir dipivoxil (ADV) for the treatment of chronic hepatitis B. To monitor for the emergence of potential...